Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2008-02-29
2009-08-04
Campell, Bruce (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C424S009100, C424S009200, C424S265100, C530S300000
Reexamination Certificate
active
07569229
ABSTRACT:
The invention relates to an anti-inflammatory oligopeptide which can be obtained from the microorganismEntamoeba histolyticaor synthesized by known methods. The oligopeptides are useful in treating inflammatory diseases when formulated in pharmaceutical compositions for administration to patients.
REFERENCES:
patent: 6524591 (2003-02-01), Schmid
patent: 7078044 (2006-07-01), Schmid
Moralez-Martinez et al. Molecular and Biochemical Parasitology, 2008, vol. 158, p. 46-51.
Delgado et al. (Nature 2001, vol. 7, p. 563-568.
Savoldo et al, Blood, vol. 108, p. 2942-2949.
Baker et al. Gene Therapy, 2003, vol. 10, p. 844-853.
Rico, et al., “Production of the Monocyte Locomotion Inhibitory Factor (MLIF) By Axenically Grown Entamoeba Histolytica: Synthesis or Degradation?” Archives of Medical Research 28:S235-S236 (1997).
Kretschmer, et al., “Inhibition of Human Monocyte Locomotion By Products of Axenically Grown E. Histolytica,” Parasite Immunology, 1985, pp. 527-543.
Rico, et al., The Monocyte Locomotion Inhibitory Factor (MLIF) Produced by Axenically Grown Entamoeba Histolytica Fails to Affect the Locomotion and the Respiratory Burst of Human Eosinophils In Vitro, Archives of Medical Research, vol. 28, Suppl., pp. S233-S234, 1997.
Kretschmer, et al., “The Role of Mannose In the Receptor of the Monocyte Locomotion Inhibitory Factor Produced by Axenically Grown Entamoeba Histolytica,” Parasitology Research (1989) 75:245-246.
Rico, et al., “Cyclic Nucleotide Changes Induced in Human Leukocytes by a Product of Axenically Grown Entamoeba Histolytica That Inhibits Human Monocyte Locomotion,” Parisitology Research (1995) 81:158-162.
Scherer, et al., “Inhibition of Contact Cutaneous Delayed Hypersensitivity Reactions to DNBc in Guinea Pigs by the Monocyte Locomotion Inhibitory Factor (MLIF) Produced by Axenically Grown Entamoeba Hystolytica,” Archives of Medical Research, vol. 28, Suppl., pp. S237-S238, 1997.
McConchie, et al., Infection and Immunity, 2006, vol. 74, p. 6632-6641.
Rahman, et al., PloS Pathogens, 2006, vol. 2, p. 0066-0077.
Boesen Agnieszka
Campell Bruce
Center for Blood Research, Inc.
Rissman Hendricks & Oliverio LLP
LandOfFree
Monocyte locomotion inhibitory factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monocyte locomotion inhibitory factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monocyte locomotion inhibitory factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4110141